Implementation of a protocol of management of chronic kidney disease between nephrology and primary health care. Preliminary results;Resultados preliminares de la implantación de un protocolo conjunto de manejo de la enfermedad renal crónica entre atención primaria y nefrología

Nefrologia

Volumn 27, Issue 2, 2007, Pages 162-167

  Torregrosa, I ^a   Solis M ^a   Pascual, B ^a   Ramos, B ^a   Gonzalez M ^a   Ramos, C ^a   Puchades, M J ^a   Garcia R ^a   Pons, S ^a   Abarca, A ^a   Mahiques, E ^a   Alcocer, H ^a   Sanmartin A ^b   Navarro, J ^b   Miguel Carrasco, Alfonso ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Centros de Salud   (Mexico)

Author keywords

Chronic kidney disease; Nephrology; Primary health care; Protocol

Indexed keywords

AGED; ARTICLE; CHRONIC DISEASE; HUMAN; KIDNEY DISEASE; NEPHROLOGY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; GUIDELINE ADHERENCE; HUMANS; KIDNEY DISEASES; NEPHROLOGY; PRIMARY HEALTH CARE;

EID: 34548383866     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Fernández-Fresnedo G, De Francisco AL, Rodrigo E, Pinera C, Herraez I, Ruiz JC, Arias M: Insuficiencia renal oculta por valoración de la función renal mediante la creatinina sérica. Nefrología 22: 95-7, 2002.
2. Otero A, Abelleira A, Camba MJ, Pérez C, Armada E, Esteban J y cols.: Prevalencia de insuficiencia renal oculta en la provincia de Ourense. Nefrología 23 (Supl. 6): 26, 2003.
3. Simal F, Martín Escudero JC, Bellido J, Arzua D, Mena FJ, González I, Álvarez AA, Tabuyo MB, Molina A: Prevalencia de la enfermedad renal crónica leve y moderada en población general. Estudio Hortega. Nefrología 24: 329-32, 334, 336-7, 2004.
4. Otero A, Abelleira A, Gayoso P: Occult chronic renal disease (OCRD) and associated vascular risk factors (VRF). Epidemiological study. Nefrología 25: 275-87, 2005.
5. Otero A, Gayoso P, García F, De Francisco AL, on behalf of the EPIRCE study group: epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study. Kidney Int (Supl. 99): S16-9, 2005.
6. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003.
7. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC: Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 14 (Supl. 2): S131-8, 2003.
8. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy DE: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56: 2214-9, 1999.
9. Hillege HL, Fidler V, Diercks GF, Van Gilst WH, De Zeeuw D, Van Veldhuisen DJ, Gans RO, Janssen WM, Grobee DE, De Jong PE, PREVEND Study Group: urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-82, 2002.
10. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm L, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease. Hypertension 42: 1050-1065, 2003.
11. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod, B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-15, 2004.
12. Yuyun MF, Khaw KT, Luben R, Wech A, Bingham S, Day NE, Wareham NJ; European prospective Investigation into Cancer in Norfolk (EPIC_Norfolk) population study. Int J Epidemiol 33: 189-98, 2004.
13. Keith DS, Nichols GA, Guillón CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large maneged care organization. Arch Intern Med 164: 659-63, 2004.
14. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351: 1296-305, 2004.
15. Foley RN, Wang C, Collins AJ: Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin Proc 80: 1267-9, 2005.
16. Foley RN, Murray AM, Shuling L, Herzog CA, McBean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare Population, 1998 to 1999. J Am Soc Nephrol 16: 489-95, 2005.
17. Schrier RW: Role of diminished renal function in cardiovascular mortality. marker or pathogenetic factor? J Am Coll Cardiol 47: 1-8, 2006.
18. Go AS, Lo JC: Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens 15: 296-302, 2006.
19. Mann JF, Gerstein HC, Pogue J, Bosh J, Yusuf S: Renal insufficienciy as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134: 629-36, 2001.
20. Asselbergs FW y cols.: Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 110: 2809-16, 2004.
21. Pinkau T, Hilgers KF, Veelken R, Mann, JFE: How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease? J Am Soc Nephrol 15: 517-23, 2004.
22. International Society of Nephrology Commission for the Global Advancement of Nephrology Study Group 2004: Prevention of chronic kidney and vascular disease: toward global health equity -the Bellagio 2004 Declaration. Kidney Int (Supl. 98): S1-6, 2005.
23. De Zeeuw D, Hillege HL, De Jong PE: The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int (Supl. 98): S25-9, 2005.
24. Remuzzi G, Ruggenenti P, Perna A, Dimitrov BD, de Zeeuw D, Hille DA, Shahinfar S, Carides GW, Brenner BM, RENAAL Study Group: Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of RENAAL trial results. J AM Soc Nephrol 15: 3117-25, 2004.
25. Pohl MA, Blunenthal S, Cordonnier DJ, De Álvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsiker LG, De Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ: Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 16: 3027-37, 2005.
26. Casas JP, Chua W, Loukogeorgakis S, Vayanse P, Smeeth L, Hingorami AD, MacAllister RJ: Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcome: systematic review and meta-analysis. Lancet 366: 2026-33, 2005.
27. Remuzzi G, Macía M, Ruggenenti P: Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Neprhrol 17 (Supl. 2): S90-7, 2006.
28. Documento de Consenso 2002 sobre pautas de detección, prevención y tratamiento de la nefropatía diabética en España. Nefrología 22: 521-530, 2002.
29. Nacional Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease. Am J Kidney Dis 39 (Supl. 1): S1-S246, 2002.
30. Górriz JL, Sancho A, Pallardó LM, Amoedo ML, Martín M, Sanz P, Barril G, Selgas R, Selgueira M, Palma A, De la Torre M, Ferreras I: Significado pronóstico de la diálisis programada en pacientes que inician tratamiento sustitutivo renal. Un estudio multicéntrico español. Nefrología 22: 49-59, 2002.
31. Marín R: Guías SEN: Riñón y enfermedad cardiovascular. Nefrología 24 (Supl. 6), 2004.
32. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-100, 2005.
33. Alcázar R, De Francisco ALM: Acción estratégica de la SEN frente a la enfermedad renal. Nefrología 26: 1-4, 2006.
34. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Gropup. Ann Intern Med 130: 461-470, 1999.
35. Levey AS, Greene T, Kusek JW, Beck JB, Group MS: A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 11: A0828, 2000.
36. Rodrigo E, De Francisco AL, Escallada R, Ruiz JC, Fresnedo GF, Piñera C, Arias M: Measurement of renal function in pre-ESRD patients. Kidney Int 61 (Supl. 80): S11-S17, 2002.
37. Lin J, Knight EL, Hogan ML, Singh AK: A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 14: 2573-80, 2003.
38. Stevens LA, Levey AS: Measurament of kidney function. Med Clin North Am 89: 457-73, 2005.
39. Rosner MH, Bolton WK: Renal Function Testing. Am J Kidney Dis 47: 174-83, 2006.
40. Gansevoort RT, Bakker SJ, De Jong PE: Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol 17: 1218-1220, 2006.
41. Villafruela JJ: Valoración rutinaria de la afectación renal en atención primaria: claves para el futuro. Nefrología 25 (Supl. 4): S57-S65, 2005.